Health Care & Life Sciences » Pharmaceuticals | Jeil Pharmaceutical Co. Ltd.

Jeil Pharmaceutical Co. Ltd. | Income Statement

Fiscal year is January-December. All values KRW Millions.
2013
2014
2015
2016
2017
2018
Sales/Revenue
451,968
512,736
594,716
40,604
44,441
137,609
Cost of Goods Sold (COGS) incl. D&A
343,984
384,717
456,033
25,106
23,246
86,444
Gross Income
107,984
128,020
138,683
15,498
21,195
51,165
SG&A Expense
106,611
113,975
124,837
12,090
20,345
44,801
EBIT
1,373
8,551
13,148
-
572
5,822
Unusual Expense
1,170
82
-
-
-
622
Non Operating Income/Expense
1,157
2,341
2,352
25
894
330
Interest Expense
754
659
573
48
19
1,017
Pretax Income
978
10,395
15,080
5,842
3,537
9,788
Income Tax
1,614
9,739
6,288
2,082
490
2,486
Equity in Affiliates
1,120
1,440
970
-
-
-
Consolidated Net Income
484
2,095
9,761
3,760
4,027
7,302
Net Income
484
2,095
9,761
2,178
3,502
7,070
Net Income After Extraordinaries
484
2,095
9,761
1,952
511,813
7,070
Net Income Available to Common
484
2,095
9,761
6,308
5,606
7,070
EPS (Basic)
126.44
550.19
2,597.17
1,691.57
1,499.00
1,363
Basic Shares Outstanding
4
4
4
4
4
5
EPS (Diluted)
126.04
551.26
2,598.29
1,692.60
138,706.89
1,362.57
Diluted Shares Outstanding
4
4
4
4
4
5
EBITDA
9,743
17,096
21,613
3,572
816
7,480
Other Operating Expense
-
5,493
697
78
278
542
Non-Operating Interest Income
372
243
152
3
82
148
Minority Interest Expense
-
-
-
1,582
525
232
Equity in Affiliates (Pretax)
-
-
-
2,532
3,796
5,128

About Jeil Pharmaceutical Co.

View Profile
Address
343 Sapyeong-daero
Seoul SL 06543
Korea, Republic Of
Employees -
Website -
Updated 07/08/2019
Jeil Pharma Holdings, Inc. engages in the manufacture and sale of pharmaceutical products. Its products include active pharmaceutical ingredients and finished dosage forms. The active pharmaceutical ingredients provide medicines for antibiotic, oncology, cardiovascular, gastrointestinal, neuropsychiatry, urology, endocrinology, respiratory, antiviral, and musculoskeletal.